Siloam International Hospitals (SILO) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.042x

Based on the latest financial reports, Siloam International Hospitals (SILO) has a cash flow conversion efficiency ratio of 0.042x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp388.57 Billion ≈ $22.77 Million USD) by net assets (Rp9.25 Trillion ≈ $541.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Siloam International Hospitals - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Siloam International Hospitals's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Siloam International Hospitals (SILO) financial obligations for a breakdown of total debt and financial obligations.

Siloam International Hospitals Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Siloam International Hospitals ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Compañía Cervecerías Unidas S.A
F:CVU
-0.020x
Grupo Lamosa S.A.B. de C.V
MX:LAMOSA
0.104x
Babcock & Wilcox Enterprises Inc
NYSE:BW
0.023x
Newell Rubbermaid Inc.
NASDAQ:NWL
0.067x
Shanghai Liangxin Electrical Co Ltd
SHE:002706
0.042x
Northking Information Technology Co
SHE:002987
0.027x
Region Group
AU:RGN
0.031x
Sichuan Jiuzhou Electronic Co Ltd
SHE:000801
0.027x

Annual Cash Flow Conversion Efficiency for Siloam International Hospitals (2010–2024)

The table below shows the annual cash flow conversion efficiency of Siloam International Hospitals from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Siloam International Hospitals (SILO) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp8.75 Trillion
≈ $512.81 Million
Rp2.33 Trillion
≈ $136.54 Million
0.266x +2.11%
2023-12-31 Rp8.05 Trillion
≈ $471.56 Million
Rp2.10 Trillion
≈ $122.96 Million
0.261x +22.99%
2022-12-31 Rp7.05 Trillion
≈ $413.19 Million
Rp1.50 Trillion
≈ $87.60 Million
0.212x -31.97%
2021-12-31 Rp6.52 Trillion
≈ $382.28 Million
Rp2.03 Trillion
≈ $119.13 Million
0.312x +40.32%
2020-12-31 Rp6.02 Trillion
≈ $352.65 Million
Rp1.34 Trillion
≈ $78.32 Million
0.222x +104.11%
2019-12-31 Rp5.99 Trillion
≈ $350.85 Million
Rp651.51 Billion
≈ $38.18 Million
0.109x +237.51%
2018-12-31 Rp6.32 Trillion
≈ $370.13 Million
Rp203.64 Billion
≈ $11.93 Million
0.032x -9.85%
2017-12-31 Rp6.31 Trillion
≈ $369.95 Million
Rp225.78 Billion
≈ $13.23 Million
0.036x -53.35%
2016-12-31 Rp3.13 Trillion
≈ $183.35 Million
Rp239.87 Billion
≈ $14.06 Million
0.077x -47.72%
2015-12-31 Rp1.74 Trillion
≈ $101.95 Million
Rp255.15 Billion
≈ $14.95 Million
0.147x -14.52%
2014-12-31 Rp1.65 Trillion
≈ $96.90 Million
Rp283.68 Billion
≈ $16.62 Million
0.172x +48.41%
2013-12-31 Rp1.64 Trillion
≈ $96.04 Million
Rp189.45 Billion
≈ $11.10 Million
0.116x -86.07%
2012-12-31 Rp244.64 Billion
≈ $14.33 Million
Rp203.01 Billion
≈ $11.90 Million
0.830x +177.97%
2011-12-31 Rp178.96 Billion
≈ $10.49 Million
Rp53.43 Billion
≈ $3.13 Million
0.299x -84.41%
2010-12-31 Rp137.58 Billion
≈ $8.06 Million
Rp263.40 Billion
≈ $15.43 Million
1.915x --

About Siloam International Hospitals

JK:SILO Indonesia Medical Care Facilities
Market Cap
$1.90 Billion
Rp32.47 Trillion IDR
Market Cap Rank
#6461 Global
#57 in Indonesia
Share Price
Rp2500.00
Change (1 day)
-0.79%
52-Week Range
Rp1845.00 - Rp2880.00
All Time High
Rp3750.00
About

PT Siloam International Hospitals Tbk operates hospitals and clinics in Indonesia. The company offers general, pre-marital, and lite checkups; male and female screenings; heart, kidney, and cancer screenings; visa application and preemployment screenings; and vaccine and genomic testing services. It also provides diagnostic services, including laboratory and radiology checks; home services; COVID… Read more